Author: Lancet
Publication Date:
This paper presents the results of an open-label, individually randomized controlled trial of a single dose of a modern intravenous iron formulation, ferric carboxymaltose, for anaemia treatment in pregnant women in Malawi with a singleton pregnancy of 13–26 weeks' gestation in primary care and outpatient settings.
![Thumbnail of journal article](/sites/default/files/styles/thumb_resource/public/2023-06/Ferric_carboxymaltose_versus_standard-of-care_oral_iron.png?itok=lR4MizpJ)